Two distinct types of oropharynx cancer have emerged over the last few years, namely HPV related and HPV unrelated oropharynx cancer. HPV related oropharyngeal carcinoma has a separate staging system and these cancers generally do better than their stage matched HPV unrelated counterparts. This chapter focuses on history, examination, evaluation, and management of oropharynx cancers with an emphasis on the role of radiation.
KeywordsOropharynx cancer Human papillomavirus Radiotherapy Intensity modulated radiotherapy
- 1.NCCN Clinical Practice Guidelines in Oncology: Smoking Cessation. https://www.nccn.org/professionals/physician_gls/pdf/smoking.pdf. 2018. Accessed 23 Dec 2018.
- 6.Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48(1):7–16.CrossRefGoogle Scholar
- 8.Gregoire V, Evans M, Le QT, et al. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 2018;126(1):3–24.CrossRefGoogle Scholar
- 14.Edge SB. American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.Google Scholar